Describe Clostridium botulinum and botulism with its clinical forms and management.

Organism and Toxin

• Clostridium botulinum — a gram-positive, motile, obligate anaerobic bacillus with an oval, subterminal, bulging spore, widely distributed in soil and marine sediment
• Botulinum toxin is the most potent poison known — a few micrograms are lethal for man; there are seven types (A to G), of which A, B and E cause most human disease
• The toxin is heat-labile, destroyed by boiling for 10 minutes, whereas the spores are heat-resistant — a distinction with direct practical consequences for food preservation

Toxin is absorbed from the gut (or produced in a wound or in the infant gut) → It travels in the blood to peripheral cholinergic nerve endings → It cleaves snare proteins (snap-25, syntaxin, synaptobrevin) → Release of acetylcholine at the neuromuscular junction is blocked → flaccid paralysis, descending and symmetrical → Autonomic cholinergic synapses are also blocked — dry mouth, ileus, urinary retention, fixed dilated pupils

Clinical Forms

Diagnosis and Treatment

• Diagnosis is clinical and treatment must not wait for confirmation
• Confirmation — detection of toxin in serum, faeces, gastric contents or the suspect food by the mouse bioassay or ELISA; culture of the organism from faeces or wound
• Differential diagnosis — Guillain-Barré syndrome (ascending and with sensory involvement), myasthenia gravis (fatigable, responds to edrophonium), stroke, and organophosphate poisoning (which causes cholinergic excess rather than deficiency)
• Treatment — trivalent or heptavalent antitoxin given as early as possible, since it neutralises only circulating toxin and cannot reverse binding already achieved; mechanical ventilation, which is the measure that actually saves lives and may be needed for weeks or months; wound debridement and antibiotics in wound botulism; and human botulinum immunoglobulin in infant botulism
• Antibiotics are not given in infant botulism, since lysis of organisms in the gut releases more toxin; and aminoglycosides are avoided as they worsen neuromuscular blockade

Therapeutic Use and Applied Aspects

• Botulinum toxin type A is used therapeutically in blepharospasm, strabismus, cervical dystonia, spasticity, achalasia, anal fissure, hyperhidrosis, chronic migraine and detrusor overactivity — and cosmetically for wrinkles. The effect lasts about 3 months as nerve terminals sprout anew
• Prevention in food — proper pressure canning to destroy spores, adequate acidity and salt, refrigeration, and boiling food for 10 minutes before consumption, which destroys the heat-labile toxin even if spores survived
• Discard bulging or damaged cans without tasting; gas production suggests clostridial growth
• Never give honey to an infant under 1 year
• Botulinum toxin is classed as a bioterrorism agent because of its extreme potency and the possibility of aerosol or food-supply dissemination
• Traditional home preservation carries the greatest risk — bottling, pickling and fermenting at home without adequate acidity or pressure canning, which is where most sporadic cases originate
• Recognising botulism early matters more than any drug, since the decisive intervention is anticipating respiratory failure and securing the airway before it occurs; vital capacity should be monitored rather than waiting for distress